Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: J R Stat Soc Ser C Appl Stat. 2012 May 31;61(4):577–599. doi: 10.1111/j.1467-9876.2012.01041.x

Table 6.

Estimates of the dynamic treatment regime marginal structural model and corresponding 95% bootstrap confidence intervals allowing for a squared threshold term, comparing the always atypical (AA) regime with the perphenazine and atypical (PA) regime. The outcome model additionally adjusted for baseline covariates (estimates provided in the Appendix). The parameter PA(θ = 30) corresponds to the expected 12-month outcome for the always treat with perphenazine regime, thus, is equal to β̂2 + β̂330 from Eq. (4).

12-month PANSS score 12-month QOL score
Covariates MI est. Avg Boot est. 95% Boot CI MI est Avg Boot est. 95% Boot CI
AA 62.9 62.9 (50.9, 74.7) 4.3 4.2 (3.5, 5.2)
PA(θ = 30) 60.8 61.3 (58.2, 73.0) 4.2 4.2 (3.3, 5.2)
Threshold, θ 7.7×10−1 6.7×10−1 (3.3×10−1, 1.02) −2.5×10−2 −1.4×10−2 (−4.0, 1.0)×10−2
Threshold2, θ2 −6.0×10−3 −5.2×10−3 (−8.6, −2.0)×10−3 −2.0×10−4 1.0×10−4 (−1.4, 3.0)×10−4